XML 45 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations (Tables)
12 Months Ended
Dec. 31, 2020
Business Combinations [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed at the Acquisition Date
The fair value of the assets acquired at the acquisition date were as follows (in millions):
Property and equipment$0.1 
Identifiable intangible assets: 
Noncompete agreements (useful lives of 2 to 3 years)
0.7 
Trade name (useful life of 20 years)
0.9 
Goodwill9.2 
Total assets acquired$10.9 
The fair value of the assets acquired at the acquisition date were as follows (in millions):
Identifiable intangible assets:
Licenses (useful lives of 10 years)
$0.1 
Goodwill1.0 
Total assets acquired$1.1 
The fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Identifiable intangible assets: 
Noncompete agreement (useful life of 2 years)
$0.1 
Trade name (useful life of 20 years)
0.4 
Goodwill4.8 
Total assets acquired5.3 
Total liabilities assumed0.2 
Net assets acquired$5.1 
The fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Accounts receivable$10.2 
Prepaid expenses and other current assets1.7 
Property and equipment, net0.7 
Identifiable intangible assets: 
Noncompete agreements (useful lives of 5 years)
1.0 
Trade name (useful life of 6 months)
1.0 
Certificates of need (useful lives of 10 years)
34.3 
Licenses (useful lives of 10 years)
14.6 
Internal-use software (useful lives of 3 years)
0.1 
Goodwill163.9 
Other long-term assets5.0 
Total assets acquired232.5 
Liabilities assumed:
Current portion of long-term debt0.3 
Accounts payable1.2 
Accrued payroll8.1 
Other current liabilities2.0 
Long-term operating lease liabilities3.1 
Total liabilities assumed
14.7 
Net assets acquired$217.8 
The fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Operating lease right-of-use assets$0.2 
Identifiable intangible asset:
Noncompete agreements (useful lives of 5 years)
0.2 
Certificates of need (useful lives of 10 years)
2.0 
License (useful life of 10 years)
0.8 
Goodwill10.8 
Total assets acquired14.0 
Liabilities assumed:
Current operating lease liabilities0.1 
Accrued payroll0.1 
Long-term lease liabilities0.1 
Total liabilities assumed
0.3 
Net assets acquired$13.7 
The fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Property and equipment$0.1 
Identifiable intangible assets: 
Noncompete agreements (useful lives of 2 to 3 years)
1.4 
Trade names (useful lives of 20 years)
2.3 
Certificates of need (useful lives of 20 years)
12.5 
Goodwill23.2 
Total assets acquired39.5 
Total liabilities assumed0.2 
Net assets acquired$39.3 
The fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Cash and cash equivalents$1.3 
Prepaid expenses and other current assets0.3 
Property and equipment, net0.6 
Identifiable intangible assets: 
Noncompete agreements (useful lives of 5 years)
0.5 
Trade name (useful life of 1 year)
1.4 
Certificates of need (useful lives of 10 years)
16.6 
Licenses (useful lives of 10 years)
21.6 
Goodwill96.1 
Total assets acquired138.4 
Liabilities assumed:
Accounts payable1.7 
Accrued payroll4.0 
Total liabilities assumed
5.7 
Net assets acquired$132.7 
The fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Total current assets$0.1 
Identifiable intangible asset: 
Noncompete agreements (useful lives of 5 years)
0.2 
Certificates of need (useful lives of 10 years)
2.5 
Licenses (useful lives of 10 years)
1.5 
Goodwill8.9 
Total assets acquired13.2 
Total liabilities assumed0.1 
Net assets acquired$13.1 
Schedule of Noncash or Part Noncash Acquisitions
Information regarding the net cash paid for the inpatient rehabilitation acquisitions during 2020 is as follows (in millions):
Fair value of assets acquired
$1.7 
Goodwill9.2 
Fair value of noncontrolling interest owned by joint venture partner
(10.9)
Net cash paid for acquisitions
$— 
Information regarding the net cash paid for the home health and hospice acquisitions during 2020 is as follows (in millions):
Fair value of assets acquired
$0.1 
Goodwill1.0 
Net cash paid for acquisitions$1.1 
Information regarding the net cash paid for the inpatient rehabilitation acquisitions during 2019 is as follows (in millions):
Fair value of assets acquired
$0.5 
Goodwill4.8 
Fair value of liabilities assumed
(0.2)
Fair value of noncontrolling interest owned by joint venture partner
(5.1)
Net cash paid for acquisitions
$— 
Information regarding the net cash paid for Alacare is as follows (in millions):
Fair value of assets acquired
$68.6 
Goodwill163.9 
Fair value of liabilities assumed(14.7)
Net cash paid for acquisition$217.8 
Information regarding the net cash paid for the home health acquisitions during 2019 is as follows (in millions):
Fair value of assets acquired$3.2 
Goodwill10.8 
Fair value of liabilities assumed(0.3)
Net cash paid for acquisitions
$13.7 
Information regarding the net cash paid for all inpatient rehabilitation acquisitions during 2018 is as follows (in millions):
Fair value of assets acquired
$16.3 
Goodwill23.2 
Fair value of liabilities assumed(0.2)
Fair value of noncontrolling interest owned by joint venture partner
(39.3)
Net cash paid for acquisitions
$— 
Information regarding the net cash paid for Camellia is as follows (in millions):
Fair value of assets acquired, net of $1.3 million of cash acquired
$41.0 
Goodwill96.1 
Fair value of liabilities assumed(5.7)
Net cash paid for acquisition$131.4 
Information regarding the net cash paid for home health and hospice acquisitions during 2018 is as follows (in millions):
Fair value of assets acquired
$4.3 
Goodwill8.9 
Fair value of liabilities assumed(0.1)
Fair value of noncontrolling interest owned by joint venture partner
(0.6)
Net cash paid for acquisitions
$12.5 
Summary of Actual and Pro Forma Results of Operations for Acquisitions The following table summarizes the results of operations of the above mentioned acquisitions from their respective dates of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisitions been January 1, 2019 (in millions):
Net Operating RevenuesNet Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to December 31, 2020
Inpatient Rehabilitation
$— $— 
Home Health and Hospice1.5 — 
Combined entity: Supplemental pro forma from 01/01/2020-12/31/2020 (unaudited)4,650.3 284.8 
Combined entity: Supplemental pro forma from 01/01/2019-12/31/2019 (unaudited)4,626.0 360.8 
The following table summarizes the results of operations of the above mentioned acquisitions from their respective dates of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisitions been January 1, 2018 (in millions):
Net Operating RevenuesNet (Loss) Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to December 31, 2019
Inpatient Rehabilitation
$4.4 $(1.3)
Alacare58.5 1.6 
All Other Home Health and Hospice
6.5 (1.5)
Combined entity: Supplemental pro forma from 01/01/2019-12/31/2019 (unaudited)4,674.6 364.3 
Combined entity: Supplemental pro forma from 01/01/2018-12/31/2018 (unaudited)4,415.9 301.8 
The following table summarizes the results of operations of the above mentioned acquisitions from their respective dates of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisitions been January 1, 2017 (in millions):
Net Operating RevenuesNet (Loss) Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to December 31, 2018
Inpatient Rehabilitation$9.1 $(1.6)
Camellia50.0 (0.9)
All Other Home Health and Hospice3.5 (0.3)
Combined entity: Supplemental pro forma from 01/01/2018-12/31/2018 (unaudited)4,337.4 300.0 
Combined entity: Supplemental pro forma from 01/01/2017-12/31/2017 (unaudited)4,039.9 289.0